Trust analysts at Winterflood have highlighted their favoured biotech and healthcare trusts, as the sector continues its comeback after the threat of significant political reform was reduced following Donald Trump's win in the US Presidential Election a year ago.
The average discount for the AIC's Biotechnology and Healthcare sector has tightened from a weighted average of 5% a year ago to 0% today, while all but one of the funds in existence for more than a year...
Reducing volatility and maximising returns
Record organic asset growth
Global economic cycle is among the longest in history
Fixed income manager takes a more cautious approach
Duff & Phelps IM selected for real estate vehicle